Latigo Biotherapeutics has named Todd N. Smith as its new CEO, effective immediately, replacing Nima Farzan who will stay on as a strategic advisor through 2027. Smith brings over 30 years of experience in commercializing pain therapies and will guide Latigo through late-stage development and commercialization of its non-opioid pain drug pipeline, including the upcoming Phase 3 trial of onzotrigine. This leadership change aims to support Latigo's transition to a commercial-stage company following its recent IPO and strong capital position.
Latigo Biotherapeutics CEO transition is the subject, with Pluang's Health sector market data as context. For readers following health stocks, here is Pluang's market snapshot as of Nov 05, 2026 18:11 WIB: out of 150 priced US health stocks, 85 rose and 56 fell. Notable movers include Edwards Lifesciences Corporation (EW) at USD 102.62 with a 1-day change of +3.27%, Medpace Holdings Inc (MEDP) at USD 677.36 up 3.14%, and Natera Inc. (NTRA) at USD 379.00 down 3.08%.
Perimeter Group Inc. announced a net income of $304.5 million for Q3 2026, reversing a prior year loss of $90.7 million, with net sales up 24% to $389.9 million. Growth was driven by a 14% increase in Fire Safety sales and an 84% surge in Specialty P...
ACM Research reported a 37% year-over-year revenue increase to $367.7 million in Q3 2026, driven by strong demand in electrochemical plating (ECP) and advanced packaging technologies. The company is expanding manufacturing capacity and global sales e...
Purple has renewed its partnership with Lucid Motors to continue providing WiFi services across Lucid's operations in Riyadh. This renewal ensures that both staff and visitors have secure and easy internet access, supporting Lucid's growing presence ...
Investec Bank Plc, acting as joint broker to SThree Plc, disclosed public dealings involving the purchase and sale of 118,333 ordinary shares each on November 4, 2026. The transactions were conducted within a price range of 295 to 304 per share. Ther...
Investec Bank plc, acting as joint broker for Gamma Communications Plc, disclosed transactions involving nearly one million ordinary shares on November 4, 2026. The bank purchased 999,970 shares at 1098 pence each and sold 962,128 shares at prices be...
